Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold

Cited by (637)

Items 301–400 of 637

1. Cross-Site Evaluation of the Alliance to Reduce Disparities in Diabetes
   Megan A. Lewis, Carla Bann, Shawn Karns, Connie L. Hobbs, Sidney L. Holt, Jeff Brenner, Neil S. Fleming, Patria Johnson, Kathryn M. Langwell, Monica E. Peek et al. · 2014 · Health Promotion Practice
2. Performing Gadoxetic Acid–Enhanced MRI After CT for Guiding Curative Treatment of Early-Stage Hepatocellular Carcinoma: A Cost-Effectiveness Analysis
   Chong Hyun Suh, Kyung Won Kim, Seong Ho Park, So Yeon Kim, Dong‐Cheol Woo, Sangjin Shin, Junhee Pyo, Atul Bhanudas Shinagare, Nikhil H. Ramaiya, Young‐Suk Lim · 2017 · American Journal of Roentgenology
3. Changes in health-related quality of life: a compensating income variation approach
   Paul McNamee, Silvia Mendolia · 2018 · Applied Economics
4. Economic Evaluation of Extending Medicare Immunosuppressive Drug Coverage for Kidney Transplant Recipients in the Current Era
   Matthew Kadatz, John S. Gill, Jagbir Gill, Richard N. Formica, Scott W Klarenbach · 2019 · Journal of the American Society of Nephrology
5. Cost‐Effectiveness of a Novel Sleep Intervention in Infancy to Prevent Overweight in Childhood
   Eng Joo Tan, Rachael Waring Taylor, Barry J. Taylor, Vicki Brown, Alison Hayes · 2020 · Obesity
6. Economic evaluations of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in type 2 diabetic nephropathy: a systematic review
   Yunyu Huang, Qiyun Zhou, Flora M. Haaijer‐Ruskamp, Maarten Jacobus Postma · 2014 · BMC Nephrology
7. A screening strategy for latent tuberculosis in healthcare workers: Cost-effectiveness and budget impact of universal versus targeted screening
   May Ee Png, Joanne Yoong, Catherine W.M. Ong, Dale Andrew Fisher, Natasha Bagdasarian · 2019 · Infection Control and Hospital Epidemiology
8. Daily almond consumption in cardiovascular disease prevention via LDL-C change in the U.S. population: a cost-effectiveness analysis
   Jifan Wang, Michelle A. Lee Bravatti, Elizabeth J. Johnson, Gowri Raman · 2020 · BMC Public Health
9. Impact of vaccine herd-protection effects in cost-effectiveness analyses of childhood vaccinations. A quantitative comparative analysis
   Marisa K. Holubar, Maria Christina Stavroulakis, Yvonne Maldonado, John P. A. Ioannidis, Despina G. Contopoulos‐Ioannidis · 2017 · PLoS ONE
10. Training providers in hypertension guidelines: Cost-effectiveness evaluation of a continuing medical education program in South Carolina
    Justin G. Trogdon, Benjamin T. Allaire, Brent M. Egan, Daniel T. Lackland, Dory Masters · 2011 · American Heart Journal
11. Health‐related quality of life and cost‐effectiveness of treatment in subarachnoid haemorrhage
    Kirsi Malmivaara, Seppo Juvela, Juha Antero Hernesniemi, Jaakko Lappalainen, Jari O. Siironen · 2012 · European Journal of Neurology
12. The effect of comprehensive state tobacco control programs on adult cigarette smoking
    Jennifer K. Rhoads · 2012 · Journal of Health Economics
13. Who Benefits Most from Collaborative Dementia Care from a Patient and Payer Perspective? A Subgroup Cost-Effectiveness Analysis
    Anika Rädke, Bernhard Michalowsky, Jochen René Thyrian, Tilly Sabine Eichler, Feng Xie, Wolfgang U. Hoffmann · 2020 · Journal of Alzheimer s Disease
14. The value of endoscopic sinus surgery in chronic rhinosinusitis
    Michael T. Yim, Kristine A. Smith, Jeremiah A. Alt, Richard R. Orlandi · 2021 · Laryngoscope Investigative Otolaryngology
15. Cost-utility of albiglutide versus insulin lispro, insulin glargine, and sitagliptin for the treatment of type 2 diabetes in the US
    David F. Bruhn, Alan A Martin, Ruben Tavares, Barnaby Hunt, Richard Fulton Pollock · 2016 · Journal of Medical Economics
16. Estimates of utility weights in hemophilia: implications for cost-utility analysis of clotting factor prophylaxis
    Scott Dennis Grosse, Shraddha Chaugule, Joel W. Hay · 2015 · Expert Review of Pharmacoeconomics & Outcomes Research
17. Immuno-Oncology Medicines: Policy Implications and Economic Considerations
    Georges Adunlin, Jenny Dong, Maisha Kelly Freeman · 2019 · INNOVATIONS in pharmacy
18. Is the whole larger than the sum of its parts? Impact of missing data imputation in economic evaluation conducted alongside randomized controlled trials
    Bernhard Michalowsky, Wolfgang U. Hoffmann, Kevin Kennedy, Feng Xie · 2020 · The European Journal of Health Economics
19. Early cholangioscopy-assisted electrohydraulic lithotripsy in difficult biliary stones is cost-effective
    Saad Alrajhi, Alan N. Barkun, Viviane Adam, Kashi Callichurn, Myriam Martel, Olaya Isabella Brewer Gutierrez, Mouen A. Khashab, Nauzer Forbes, Majid Abdularahman Almadi, Yen‐I Chen · 2021 · Therapeutic Advances in Gastroenterology
20. The Epidemiological and Economic Impact of a Cell-Based Quadrivalent Influenza Vaccine in Adults in the US: A Dynamic Modeling Approach
    Van Hung Nguyen, Yvonne Hilsky, Joaquín Federico Mould-Quevedo · 2021 · Vaccines
21. Early Education and Adult Health: Age 37 Impacts and Economic Benefits of the Child-Parent Center Preschool Program
    Nishank Varshney, Judy A. Temple, Arthur J. Reynolds · 2022 · Journal of Benefit-Cost Analysis
22. Economic evaluation of population-based, expanded reproductive carrier screening for genetic diseases in Australia
    DEBORAH J. SCHOFIELD, Evelyn Lee, Jayamala Parmar, Simon Kelly, Matthew Hobbs, Nigel G. Laing, Jan Mumford, Rupendra N. Shrestha · 2023 · Genetics in Medicine
23. Estimating the payoffs from cardiovascular disease research in Canada: an economic analysis
    Claire de Oliveira, Hai V. Nguyen, Harindra Channa Wijeysundera, William W. L. Wong, Gloria W Woo, Paul V. Grootendorst, Peter P. Liu, Murray Dale Krahn · 2013 · CMAJ Open
24. Selecting the optimal risk threshold of diabetes risk scores to identify high-risk individuals for diabetes prevention: a cost-effectiveness analysis
    Kristin Mühlenbruch, Xiaohui Zhuo, Barbara H. Bardenheier, Hui Shao, Michael Laxy, Andrea Icks, Ping Zhang, Edward W. Gregg, Matthias Bernd Schulze · 2019 · Acta Diabetologica
25. Cost-effectiveness analysis of hepatocellular carcinoma screening by combinations of ultrasound and alpha-fetoprotein among Alaska Native people, 1983–2012
    Prabhu P. Gounder, LISA R. BULKOW, Martin I. Meltzer, Michael G. Bruce, Thomas W. Hennessy, Mary M. Snowball, Philip R. Spradling, Bishwa B. Adhikari, Brian J. McMahon · 2016 · International Journal of Circumpolar Health
26. The impact of asthma on the cost effectiveness of surgery for chronic rhinosinusitis with nasal polyps
    George A. Scangas, Aaron Kyle Remenschneider, Brooke M. Su‐Velez, Mark G. Shrime, Ralph B. Metson · 2017 · International Forum of Allergy & Rhinology
27. Value-Based Calculators in Cancer: Current State and Challenges
    Chadi Nabhan, Bruce A. Feinberg · 2017 · Journal of Oncology Practice
28. Implementation-effectiveness trial of an ecological intervention for physical activity in ethnically diverse low income senior centers
    Porchia Rich, Gregory A. Aarons, Michelle Takemoto, Verónica Cárdenas, Katie Crist, Khalisa Bolling, Brittany Lewars, Cynthia M. Castro, Loki Natarajan, Yuyan Shi et al. · 2017 · BMC Public Health
29. Cost Effectiveness of a Weight Management Program Implemented in the Worksite
    Phaedra S. Corso, Justin B. Ingels, Heather M. Padilla, Heather Zuercher, David M. DeJoy, Robert J. Vandenberg, Mark G. Wilson · 2018 · Journal of Occupational and Environmental Medicine
30. Cost-effectiveness of guideline-based stepped and collaborative care versus treatment as usual for patients with depression – a cluster-randomized trial
    Christian Brettschneider, Daniela Heddaeus, Maya Steinmann, Martin Christian Härter, Birgit Watzke, Hans‐Helmut König · 2020 · BMC Psychiatry
31. Cost-Effectiveness of Novel Oral Anticoagulants for Stroke Prevention in Non-Valvular Atrial Fibrillation
    Sheldon M. Singh, Harindra Channa Wijeysundera · 2015 · Current Cardiology Reports
32. Health economics and prioritising health care
    Martin I. Meltzer · 2008 · The Lancet
33. Newborn Screening for the Detection of the TP53 R337H Variant and Surveillance for Early Diagnosis of Pediatric Adrenocortical Tumors: Lessons Learned and Way Forward
    Karina C. F. Tosin, Edith Falcon-de Legal, Mara Albonei Dudeque Pianovski, Humberto C. Ibañez, Gislaine Custódio, Denise Siqueira de Carvalho, Mirna M. O. Figueiredo, Anselmo Hoffmann Filho, Carmem Maria Costa Mendonça Fiori, Ana Luiza Melo Rodrigues et al. · 2021 · Cancers
34. Cost-effectiveness and willing-to-pay thresholds for vertebral augmentation of osteoporotic vertebral fractures, what are they based on: a systematic review
    Gaylene E. Pron, Matthew K. Hwang, Mehran Nasralla, Roger P. Smith, Angela Cheung, Kieran Murphy · 2023 · BMJ Open
35. Definition, prevalence, and economic impacts of hypertension on the elderly population
    Cheng-Wei Lien, Yi‐Hsuan Lee, Chia‐Wen Lu, Yu-Ching Chang, Yi‐Syuan Lin, Hao‐Min Cheng, Michael Yu‐Chih Chen, Long‐Teng Lee, Cheng-Kuo Huang, Yen‐Hung Lin et al. · 2025 · Journal of the Formosan Medical Association
36. Operative Versus Nonoperative Treatment of Acute Achilles Tendon Ruptures: A Pilot Economic Decision Analysis
    Alvin W.Y. Su, Ljiljana Bogunovic, Jeffrey E. Johnson, Sandra E. Klein, Matthew J. Matava, Jeremy J. McCormick, Matthew V. Smith, Rick W. Wright, Robert H. Brophy · 2020 · Orthopaedic Journal of Sports Medicine
37. Effectiveness of a digitally supported care management programme to reduce unmet needs of family caregivers of people with dementia: study protocol for a cluster randomised controlled trial (GAIN)
    Olga A. Klein, Melanie Boekholt, Dilshad Afrin, Christina Dornquast, Adina Dreier, Armin Keller, Bernhard Michalowsky, Ina Zwingmann, Stefan Johannes Teipel, Jochen René Thyrian et al. · 2021 · Trials
38. Cost-utility Analysis of Neoadjuvant Teriparatide Therapy in Osteopenic Patients Undergoing Adult Spinal Deformity Surgery
    Micheal Raad, Carlos D. Ortiz-Babilonia, Hamid Reza Hassanzadeh, Varun Puvanesarajah, Khaled M. Kebaish, Amit Jain · 2022 · Spine
39. Cost-effectiveness of internet-delivered cognitive behaviour therapy for body dysmorphic disorder: Results from a randomised controlled trial
    Oskar Flygare, Erik Andersson, Gjermund Glimsdal, David Mataix‐Cols, Diana Radu Djurfeldt, Christian Rück, Jesper Enander · 2023 · Internet Interventions
40. Pertussis Post-Exposure Prophylaxis among Household Contacts: A Cost-Utility Analysis
    Nisha Thampi, Ipek Gurol‐Urganci, Natasha Sarah Crowcroft, Beate Sander · 2015 · PLoS ONE
41. Economic Evaluation of Prostate Cancer Screening: A Systematic Review
    Chunhuan Lao, Charis Brown, Paul Rouse, Richard P. Edlin, Ross A Lawrenson · 2015 · Future Oncology
42. Stereotactic Body Radiotherapy versus Low Dose Rate Brachytherapy for Localised Prostate Cancer: a Cost–Utility Analysis
    Joelle Antoine Helou, Sofía Torres, Hima Bindu Musunuru, Jacques Raphael, Patrick Cheung, Danny Vesprini, Hans Tse-Kan Chung, Laura D’Alimonte, Murray Dale Krahn, Gerard Morton et al. · 2017 · Clinical Oncology
43. Do reimbursement recommendation processes used by government drug plans in Canada adhere to good governance principles?
    Nigel S. B. Rawson, John Adams · 2017 · ClinicoEconomics and Outcomes Research
44. Crossing the chasm: tools to define the value of innovative endoscopic technologies to encourage adoption in clinical practice
    Eric D. Shah, Richard Ira Rothstein · 2020 · Gastrointestinal Endoscopy
45. Cost-Effectiveness Analysis of Motion-Preserving Operations for Wrist Arthritis
    Helene Retrouvey, Beate Sander, Herbert P. von Schroeder, Paul Binhammer, Heather L. Baltzer · 2020 · Plastic & Reconstructive Surgery
46. Genetic Screening for the Predisposition to Venous Thromboembolism: A Cost-Utility Analysis of Clinical Practice in the Italian Health Care System
    Amelia Compagni, Alessia Melegaro, Rosanna Tarricone · 2013 · Value in Health
47. Stool DNA Analysis is Cost-Effective for Colorectal Cancer Surveillance in Patients With Ulcerative Colitis
    John B. Kisiel, Gauree Gupta Konijeti, Andrew J. Piscitello, Tarun Chandra, Thomas F. Goss, David A. Ahlquist, Francis A. Farraye, Ashwin N. Ananthakrishnan · 2016 · Clinical Gastroenterology and Hepatology
48. The cost-effectiveness of competing congestion pricing plans in New York city
    Wenya Yu, David Suh, Shanshan Song, Boshen Jiao, Lulu Zhang, Peter Alexander Muennig · 2019 · Journal of Transport & Health
49. Challenges in assessing the clinical utility and economic value of immune checkpoint inhibitor therapies of Cancer
    Peter Paul Yu, Omar E. Eton, Louis P. Garrison · 2019 · Journal for ImmunoTherapy of Cancer
50. Is HLA-B*58:01 Genotyping Cost Effective in Guiding Allopurinol use in Gout Patients with Chronic Kidney Disease?
    Gim Gee Teng, Wei Chuen Tan‐Koi, Di Dong, Cynthia Sung · 2020 · Pharmacogenomics
51. Cost-effectiveness analysis of a fecal microbiota transplant center for treating recurrent C.difficile infection
    Seth R. Shaffer, Julia C. Witt, Laura Ellyn Targownik, Dina H. Kao, Christine Lee, Fabrice Smieliauskas, David T. Rubin, Harminder Singh, Charles Noah Bernstein · 2020 · Journal of Infection
52. Cost and cost-effectiveness of the ‘Stand and Move at Work’ multicomponent intervention to reduce workplace sedentary time and cardiometabolic risk
    Tzeyu L. Michaud, Wen You, Paul Andrew Estabrooks, Krista S. Leonard, Sarah A. Rydell, Sarah L. Mullane, Mark A. Pereira, Matthew Paul Buman · 2022 · Scandinavian Journal of Work Environment & Health
53. Cost-Effectiveness and Economic Burden Analyses on All First-Line Treatments of Chronic Lymphocytic Leukemia
    Neda Alrawashdh, Ali McBride, Brian L. Erstad, Joann Balazs Sweasy, Daniel Oscar Persky, Ivo L Abraham · 2022 · Value in Health
54. Cost-Effectiveness Analysis of Universal Screening for Biliary Atresia in Japan
    Eri Hoshino, Kensuke Moriwaki, Kosuke Morimoto, Kotomi Sakai, Nobuyuki Shimohata, Keiko Konomura, Kevin Y. Urayama, Mitsuyoshi Suzuki, Kojiro Shimozuma · 2022 · The Journal of Pediatrics
55. Health economic evaluation of preventive digital public health interventions using decision-analytic modelling: a systematized review
    Oliver Lange · 2023 · BMC Health Services Research
56. Access to Oncology Medicines in Canada: Consensus Forum for Recommendations for Improvement
    Sandeep R. Sehdev, Nigel S. B. Rawson, Olexiy Aseyev, Catriona J. Buick, Marcus Otho Butler, Scott J. Edwards, Sharlene Gill, Joanna Gotfrit, Cyrus C. Hsia, Rosalyn Anne Juergens et al. · 2024 · Current Oncology
57. Rationale and methodology for trial-based economic evaluation
    S. Petrou · 2012 · Clinical Investigation
58. The value of frontal sinusotomy for chronic rhinosinusitis with nasal polyps—A cost utility analysis
    George A. Scangas, Ashton E. Lehmann, Aaron Kyle Remenschneider, Brooke M. Su‐Velez, Mark G. Shrime, Ralph B. Metson · 2017 · The Laryngoscope
59. Cost-Effectiveness of Ventricular Assist Device Destination Therapy for Advanced Heart Failure in Duchenne Muscular Dystrophy
    Defne Magnetta, JaHyun Kang, Peter D. Wearden, Kenneth J. Smith, Brian Feingold · 2018 · Pediatric Cardiology
60. Cost-Utility Analysis of Operative Versus Nonoperative Treatment of Thoracic Adolescent Idiopathic Scoliosis
    Amit Jain, Michelle Claire Marks, Michael Patrick Kelly, Lawrence G. Lenke, Thomas J. Errico, Baron S.H. Lonner, Peter O. Newton, Paul David Sponseller · 2018 · Spine
61. Color-Flow Duplex Screening for Upper Extremity Proximity Injuries: A Low-Yield Strategy for Therapeutic Intervention
    Nathan M. Mollberg, Stephen R. Wise, Simpledeep Banipal, Ryan Sullivan, Michelle Holevar, Amir Vafa, Elizabeth Clark, Gary J. Merlotti · 2013 · Annals of Vascular Surgery
62. Pneumococcal conjugate vaccine: review of cost–effectiveness studies in Australia, North America and Europe
    Gary Thomas Ray · 2008 · Expert Review of Pharmacoeconomics & Outcomes Research
63. Cost-effectiveness of gastric band surgery for overweight but not obese adults with type 2 diabetes in the U.S
    J. Wentworth, K. Dalziel, P. O'Brien, P. Burton, Frackson Shaba, P. Clarke, N. Laiteerapong, W. Brown · 2017 · Journal of diabetes and its complications
64. Behavioral activation with mindfulness in treating subthreshold depression in primary care: A cost-utility and cost-effectiveness analysis alongside a randomized controlled trial
    Sun, Yuying, Wong, Samuel Y.S., Zhang, Dexing, Chen, Cynthia H.J., Yip, Benjamin H.K. · 2021 · Journal of Psychiatric Research
65. Imaging of Resected Nonfunctioning Pituitary Adenomas: The Cost of Surveillance
    Rebecca A. Kasl, Arash Nayeri, Andrea L. Utz, Kyle D. Weaver, Lola Blackwell Chambless, Heather M. Kistka · 2015 · Journal of Neurological Surgery Part B Skull Base
66. Thresholds for the value judgement of health technologies in the United Arab Emirates: a consensus approach through voting sessions
    Sara Ahmad Mohammad Al Dallal, Mohamed Farghaly, Sahar Fahmy, Khalid A. Alnaqbi, Wael Al Naeem, Mouza Alsaadi, Marleine Moukarzel, Ahmad Nader Fasseeh, Nada Korra, Sherif Abaza et al. · 2024 · BMJ Open
67. Current landscape in first-line treatment of metastatic hormone sensitive prostate cancer: a cost-effectiveness focused review
    Cristóbal Ávila, Jaime González‐Montero, Carlos I Rojas, Ravi Amrit Madan, Mauricio Burotto · 2025 · The Oncologist
68. Providing care for the 99.9% during the COVID-19 pandemic: How ethics, equity, epidemiology, and cost per QALY inform healthcare policy
    Stephen L. Archer · 2020 · Healthcare Management Forum
69. Comprehensive cost-effectiveness of diabetes management for the underserved in the United States: A systematic review
    Rita Bosetti, Laila S. Tabatabai, Georges Naufal, Terri L. Menser, Bita Arbab Kash · 2021 · PLoS ONE
70. The Coming Fiscal Crisis
    Martin J. Andersen, Allon N. Friedman · 2013 · Clinical Journal of the American Society of Nephrology
71. Cost-Utility Analysis
    Abhishek Chatterjee, David Macarios, Leah Passmore Griffin, Tomasz Kosowski, Bryan J. Pyfer, Anaeze Chidiebele Offodile, Daniel N. Driscoll, Sirish Maddali, John Attwood · 2015 · Plastic & Reconstructive Surgery Global Open
72. Cost-Effectiveness Analysis of Hepatitis B Virus Screening and Management in Patients With Hematologic or Solid Malignancies Anticipating Immunosuppressive Cancer Therapy
    Jessica Park Hwang, Danmeng Huang, John Moore Vierling, Maria Eugenia Suarez-Almazor, Ya‐Chen Tina Shih, Mariana Chávez‐MacGregor, Zhigang Duan, Sharon Hermes Giordano, Dawn L. Hershman, Michael Jordan Fisch et al. · 2019 · JCO Clinical Cancer Informatics
73. Impact of interventions to reduce overnutrition on healthcare costs related to obesity and type 2 diabetes: a systematic review
    Michaela Olm, Renee G. Stark, Nathanael Beck, Christina Röger, Reiner Leidl · 2019 · Nutrition Reviews
74. The cost of saving babies: How economists justify policies
    Zachary Webster Griffen, Stefan Timmermans · 2020 · Economy and Society
75. Cost-effectiveness analysis of advanced radiotherapy techniques for post-mastectomy breast cancer patients
    Yibo Xie, Beibei Guo, Rui Zhang · 2020 · Cost Effectiveness and Resource Allocation
76. Cost-Effectiveness of Extended-Release Injectable Naltrexone Among Incarcerated Persons with Opioid Use Disorder Before Release from Prison Versus after Release
    Ali Jalali, Philip J. Jeng, Daniel E. Polsky, Sabrina A. Poole, Yi-Chien Jacob Ku, GEORGE E. WOODY, Sean M. Murphy · 2022 · Journal of Substance Abuse Treatment
77. Cost-effectiveness of an internet-based booster program for patients with obsessive-compulsive disorder: Results from a randomized controlled trial
    E. Andersson, B. Ljótsson, E. Hedman, S. Mattson, Jesper Enander, G. Andersson, V. Kaldo, N. Lindefors, C. Rück · 2015 · Journal of Obsessive-Compulsive and Related Disorders
78. Cost-effectiveness of prophylaxis treatment strategies for febrile neutropenia in patients with recurrent ovarian cancer
    Kelly Fust, Xiaoyan Li, Michael Maschio, Richard L. Barron, Milton C. Weinstein, Anju Parthan, Marjan Walli-Attaei, David Chandler, Gary H. Lyman · 2014 · Gynecologic Oncology
79. The Cost-Effectiveness of Anemia Treatment for Persons with Chronic Kidney Disease
    Benjamin Yarnoff, Thomas J. Hoerger, Siobhan A. Simpson, Meda E. Pavkov, Nilka Rı́os Burrows, Sundar S. Shrestha, Desmond E. Williams, Xiaohui Zhuo · 2016 · PLoS ONE
80. The efficacy and cost-effectiveness of enoxaparin versus rivaroxaban in the prevention of venous thromboembolism following total hip or knee arthroplasty: A meta-analysis
    Joshua Xu, David Chang, Juanita Noeline Chui, Jacob Cao, Jonathan J. Negus · 2022 · Journal of Orthopaedics
81. Cost-effectiveness Analysis of Digital Therapeutics for Amblyopia
    Irene Koc, Saghar Bagheri, Rachel K. Chau, Sandra Hoyek, Nour Abou Shousha, Golnoush Mahmoudinezhad, Michelle M. Falcone, Isdin Oke, David G. Hunter, Nimesh A. Patel · 2025 · Ophthalmology
82. Sentinel node biopsy in patients with primary cutaneous melanoma of any thickness: A cost-effectiveness analysis
    Patricia Serra-Arbeloa, Á.O. Rabines-Juárez, M.S. Álvarez-Ruiz, Francisco Guillén‐Grima · 2016 · Surgical Oncology
83. Cost-utility Analysis Comparing Bracing Versus Observation for Skeletally Immature Patients with Thoracic Scoliosis
    Ijezie Ikwuezunma, Kevin Wang, Adam Margalit, Paul Sponseller, Amit Jain · 2021 · Spine
84. Uncertainty in the Cost-Effectiveness of Federal Air Quality Regulations
    Kerry Krutilla, David H. Good, John D. Graham · 2015 · Journal of Benefit-Cost Analysis
85. Cost-Effectiveness of Maraviroc for Antiretroviral Treatment-Experienced HIV-infected Individuals in Mexico
    I Contreras-Hernández, Debbie L. Becker, Jeremy V.M. Chancellor, Felicitas Kühne, Joaquín Federico Mould-Quevedo, Gabriela Castro Vega, Shalaka Marfatia · 2010 · Value in Health
86. Rethinking cost-effectiveness in the era of zero healthcare spending growth
    Ronen Arbel, Dan Greenberg · 2016 · International Journal for Equity in Health
87. Screening and Treatment for Subclinical Hypertensive Heart Disease in Emergency Department Patients With Uncontrolled Blood Pressure: A Cost‐effectiveness Analysis
    Michael J. Twiner, Alexander L. Marinica, Kenneth Kuper, Allen C. Goodman, James J. Mahn, Michael J. Burla, Aaron Brody, Justin A. Carroll, Robina Josiah Willock, John M. Flack et al. · 2017 · Academic Emergency Medicine
88. Cost-Effectiveness of Multidisciplinary Management Program and Exercise Training Program in Heart Failure
    Weixiong Dang, Anji Yi, Sunny Jhamnani, Shi‐Yi Wang · 2017 · The American Journal of Cardiology
89. Biosimilars in inflammatory bowel disease
    Saurabh Talathi, Kondal R. Kyanam Kabir Baig · 2020 · Journal of Digestive Diseases
90. Economic Evaluation of In-Hospital Clinical Practices in Acute Injury Care: A Systematic Review
    Blanchard Conombo, Jason R. Guertin, Pier‐Alexandre Tardif, Marc‐Aurèle Gagnon, Cécile Duval, Patrick Michel Archambault, Simon Berthelot, François Lauzier, Alexis F. Turgeon, Henry T. Stelfox et al. · 2021 · Value in Health
91. A cost-benefit analysis of lipid standardization in the United States.
    Thomas J. Hoerger, John S. Wittenborn, Walter F. Young · 2011 · Europe PMC (PubMed Central)
92. Effect of Workplace Weight Management on Health Care Expenditures and Quality of Life
    Tzeyu L. Michaud, John A. Nyman, Eric Jutkowitz, Dejun Su, Bryan E Dowd, Jean Marie Abraham · 2016 · Journal of Occupational and Environmental Medicine
93. Estimation of Health and Economic Benefits of a Small Automatic External Defibrillator for Rapid Treatment of Sudden Cardiac Arrest (SMART): A Cost-Effectiveness Analysis
    Marcus S Shaker, Elissa Michele Abrams, John J Oppenheimer, Alexander G. Singer, Matthew Shaker, Daniel Fleck, Matthew Greenhawt, Evan Grove · 2022 · Frontiers in Cardiovascular Medicine
94. Social value of a quality-adjusted life year (QALY) in Spain: the point of view of oncologists
    Carlos Camps, Luis G Paz-Ares, M. Codes, Rafael López‐López, Antonio Antón-Torres, P. Gascón-Vilaplana, Vicente Guillem-Porta, Alfredo Carrato, Juan Jesús Cruz, C. Caballero-Díaz et al. · 2014 · Clinical & Translational Oncology
95. Pharmacoeconomics of obesity in China: a scoping review
    Zhuo Chen, Shan Jiang, Youfa Wang, M. Mahmud Khan, Donglan “Stacy” Zhang, Janani Rajbhandari‐Thapa, Li Li · 2021 · Expert Review of Pharmacoeconomics & Outcomes Research
96. Cost-Effectiveness of Colorectal Cancer Genetic Testing
    Abdul Rahman Ramdzan, Mohd Rizal Abdul Manaf, Azimatun Noor Aizuddin, Zarina Abdul Latiff, Keng Wee Teik, Gaik-Siew Ch’ng, Kurubaran Ganasegeran, Syed Mohamed Aljunid · 2021 · International Journal of Environmental Research and Public Health
97. Evaluación económica comparativa sobre terapias de reemplazo renal en Argentina, Costa Rica y Uruguay
    Santiago Torales, José Berardo, Santiago Hasdeu, María Paula Esquivel, Alfonso Izita Rosales, Carlos Azofeifa Chacón, Jordan Salazar, Manuel Cerdas, Óscar Gianneo, Martín Esteche et al. · 2021 · Revista Panamericana de Salud Pública
98. Cost-Effectiveness of Meningococcal Vaccination Among Men Who Have Sex With Men in New York City
    Matthew S. Simon, Don Weiss, Anita Geevarughese, Molly M Kratz, Blayne H. Cutler, Roy M. Gulick, Jane R. Zucker, Jay K. Varma, Bruce R. Schackman · 2015 · JAIDS Journal of Acquired Immune Deficiency Syndromes
99. Pre-emptive virology screening in the pediatric hematopoietic stem cell transplant population
    Patrick D. Evers · 2013 · Hematology/Oncology and Stem Cell Therapy
100. Use of Economic Evaluation in Decision Making
     Steven Simoens · 2010 · Drugs